| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.094 | 0.05 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.05 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.064 | 0.06 |